The HemOnc Pulse

Rahul Banerjee, MD

Blood Cancers Today and the Society of Hematologic Oncology bring you The HemOnc Pulse, a podcast hosted by Rahul Banerjee, MD, covering all topics in the world of hematologic oncology.

  1. 23 HRS AGO · BONUS

    Editor's Special Episode: Future Directions in MPN Treatment with Dr. Hobbs

    Dr. Hobbs joins the podcast to discuss the latest advances in myeloproliferative neoplasms (MPNs), including ropeginterferon and the VERIFY trial of rusfertide in polycythemia vera. He highlights key efficacy and safety data, unmet needs in essential thrombocythemia and myelofibrosis, and the next wave of clinical trials to watch.

    17 min

  2. SEP 12

    Clinical Advances in Myeloma: A Nordic Perspective

    Host Rahul Banerjee, MD, speaks with Drs. Frederik Schjesvold and Frida Askeland on myeloma trial results, relevance in the IMROZ/CEPHEUS era, and advances in treating elderly, frail patients.

    12 min

  3. SEP 7

    Grand Rounds in Leukemia: MD Anderson Fellows on AML Endpoints

    MD Anderson fellows discuss AML, MRD endpoints, and evolving trial strategies in a dynamic grand rounds–style presentation.

    9 min

  4. AUG 27 · BONUS

    Editor’s Special Episode: Progress and Prospects in CLL Management

    William Wierda, MD, PhD of the University of Texas MD Anderson discusses advances in chronic lymphocytic leukemia care, from targeted therapies and resistance to immune dysfunction and prevention with Blood Cancers Today Managing Editor, Nichole Tucker.

  5. AUG 22 · BONUS

    Today’s Clinical Trials Define the Next Era in Myeloma

    In this Editor’s Special Episode of The HemOnc Pulse, Dr. Hira Mian of McMaster University shares expert insights on the evolving treatment landscape for multiple myeloma. From optimizing selinexor use, to understanding long-term MonumenTAL-1 data with talquetamab, to the promise of emerging trispecific antibodies, Dr. Mian highlights the biggest shifts shaping care today.

  6. AUG 15

    ‘The HemOnc Pulse Live:’ Transforming ALL Treatment Pathways

    A panel of hematology leaders discusses the latest in ALL and T-cell ALL therapy, including TKI+blina combinations, venetoclax strategies, and the emerging role of CD7 CAR T-cell therapies in reshaping treatment paradigms.

  7. AUG 8 · BONUS

    Evolving Approaches in the Management of MDS

    Review of IMerge phase 3 data on imetelstat for lower-risk MDS and how prior therapies affect treatment outcomes, and other ASCO 2025 MDS updates with Andrew Brunner, MD.

    32 min

  8. AUG 1

    ‘The HemOnc Pulse Live!’: AML in Transition

    During a session at The HemOnc Pulse Live! moderated by Naval Daver, MD, Eunice Wang, MD presents new insights in acute myeloid leukemia care, joined by Aditi Shastri, MBBS, Tapan Kadiya, MD, and Kelly Chien, MD for a rich panel on mutation loss, minimal residual disease, and transplant timing.

See All (77)

About

Blood Cancers Today and the Society of Hematologic Oncology bring you The HemOnc Pulse, a podcast hosted by Rahul Banerjee, MD, covering all topics in the world of hematologic oncology.

Information

  • Creator
    Rahul Banerjee, MD
  • Years Active
    2022 - 2025
  • Episodes
    77
  • Rating
    Clean
  • Copyright
    © Copyright 2025 All rights reserved.
  • Show Website
    The HemOnc Pulse

You Might Also Like